Annual report pursuant to Section 13 and 15(d)

Consolidated Income Statements

v3.22.0.1
Consolidated Income Statements - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenues:    
Total revenues $ 80,859,653 $ 58,682,976
Cost of revenues:    
Total cost of revenues 8,513,777 6,507,468
Selling and marketing expenses 11,424,416 7,804,420
Depreciation and amortization 6,088,947 2,734,462
General and administrative expenses 49,453,305 36,195,817
Total selling, general and administrative expenses 66,966,668 46,734,699
Net loss (gain) on disposition or impairment 26,789 (51,321)
Income from operations 5,352,419 5,492,130
Other expense, net (69,878) (79,478)
Income before income tax benefit 5,282,541 5,412,652
Income tax benefit (1,293,229) (7,754,662)
Net income $ 6,575,770 $ 13,167,314
Earnings per share:    
Basic earnings per share (in dollars per share) $ 0.46 $ 0.94
Diluted earnings per share (in dollars per share) $ 0.44 $ 0.90
Basic weighted average shares (in shares) 14,319,448 14,003,708
Diluted weighted average shares (in shares) 14,935,577 14,582,877
Revenues from company-owned or managed clinics    
Revenues:    
Total revenues $ 44,348,234 $ 31,757,207
Royalty fees    
Revenues:    
Total revenues 22,062,989 15,886,051
Franchise fees    
Revenues:    
Total revenues 2,659,097 2,100,800
Cost of revenues:    
Cost of revenues 7,408,125 6,090,203
Advertising fund revenue    
Revenues:    
Total revenues 6,298,924 4,506,413
Software fees    
Revenues:    
Total revenues 3,383,856 2,694,520
Cost of revenues:    
Cost of revenues 1,105,652 417,265
Regional developer fees    
Revenues:    
Total revenues 848,640 876,804
Other revenues    
Revenues:    
Total revenues $ 1,257,913 $ 861,181